We can't find the internet
Attempting to reconnect
9949.1;5 PFLS-LS
Development of small molecule inhibitors of the respiratory syncytial virus polymerase complex.
Zusammenfassung
Development of small molecule inhibitors of the respiratory syncytial virus polymerase complex.
Weitere Texte
Abstract
Respiratory syncytial virus (RSV) is the principal cause of lower respiratory disease in infants and children necessitating 75,000 hospitalizations per year in the US alone. Despite its importance as a pathogen, there is neither a treatment nor a vaccine against RSV available. The project partners will develop novel, first-in-class antiviral drug candidates disrupting the interaction between two proteins of the RSV replicase complex, which is crucial for virus propagation.
Beteiligte
Pius August Schubiger
Kontaktperson
august.schubiger@pharma.ethz.ch
ETH Zürich Pius August Schubiger Wolfgang-Pauli-Strasse 10 Institut für Pharmazeutische Wissen 8093 Zürich ZH CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2009-01-31
- Enddatum
- 2014-02-13
- Bewilligte Gesamtkosten
- CHF 351051.00
- Sektion
- 20 Förderbereich Life Sciences
- NABS Politikbereich
- Nicht aufteilbare / nicht zuteilbare Forschung
Forschungsdisziplinen
- T115 Medical technology 100.0%